385 related articles for article (PubMed ID: 10620486)
1. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
[TBL] [Abstract][Full Text] [Related]
2. Succimer and the reduction of tissue lead in juvenile monkeys.
Smith DR; Woolard D; Luck ML; Laughlin NK
Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
Smith D; Bayer L; Strupp BJ
Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
[TBL] [Abstract][Full Text] [Related]
4. The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer.
Seaton CL; Lasman J; Smith DR
Toxicol Appl Pharmacol; 1999 Sep; 159(3):153-60. PubMed ID: 10486301
[TBL] [Abstract][Full Text] [Related]
5. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
[TBL] [Abstract][Full Text] [Related]
6. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
[TBL] [Abstract][Full Text] [Related]
7. The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.
Lasky RE; Laughlin NK; Luck ML
Environ Res; 2001 Sep; 87(1):21-30. PubMed ID: 11534961
[TBL] [Abstract][Full Text] [Related]
8. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
Gong Z; Evans HL
Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
[TBL] [Abstract][Full Text] [Related]
9. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
10. Chelated lead in relation to lead in bone and ALAD genotype.
Gerhardsson L; Börjesson J; Mattsson S; Schütz A; Skerfving S
Environ Res; 1999 May; 80(4):389-98. PubMed ID: 10330313
[TBL] [Abstract][Full Text] [Related]
11. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
Cory-Slechta DA
J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
[TBL] [Abstract][Full Text] [Related]
12. Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.
Ramsey DT; Casteel SW; Faggella AM; Chastain CB; Nunn JW; Schaeffer DJ
J Am Vet Med Assoc; 1996 Feb; 208(3):371-5. PubMed ID: 8575967
[TBL] [Abstract][Full Text] [Related]
13. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
14. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
[TBL] [Abstract][Full Text] [Related]
15. The scientific basis for chelation: animal studies and lead chelation.
Smith D; Strupp BJ
J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
[TBL] [Abstract][Full Text] [Related]
16. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
Saxena G; Pathak U; Flora SJ
Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
[TBL] [Abstract][Full Text] [Related]
17. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead.
Kala SV; Jadhav AL
Neurotoxicology; 1995; 16(2):297-308. PubMed ID: 7566689
[TBL] [Abstract][Full Text] [Related]
18. Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats.
Saxena G; Flora SJ
J Pharm Pharmacol; 2006 Apr; 58(4):547-59. PubMed ID: 16597373
[TBL] [Abstract][Full Text] [Related]
19. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
Bradberry S; Sheehan T; Vale A
QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
[TBL] [Abstract][Full Text] [Related]
20. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
Aslani MR; Najarnezhad V; Mohri M
Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
